Bonvir 150mg

Bonviva 150mg: A Treatment for Postmenopausal Osteoporosis.

Bonviva 150mg is a medication used to treat osteoporosis in postmenopausal women who are at risk of developing bone fractures. It contains the active substance ibandronic acid, which helps increase bone mineral density and reduce the risk of vertebral fractures. However, the efficacy on femoral neck fractures has not been established.

Bonviva is available as tablets and as a solution for injection in a prefilled syringe. It is recommended to take one 150mg tablet once a month on the same day each month. For optimal absorption, it is best to take Bonviva at least 60 minutes before the first food or drink of the day, or before taking any oral medication or supplements like calcium, antacids, or vitamins.

Regular use of Bonviva can help manage osteoporosis and reduce the risk of fractures, making it an essential treatment option for postmenopausal women with this condition. Patients should have their need for continued therapy re-evaluated periodically, especially those at low risk for fracture, as the optimal duration of use has not been determined.